文献速递肝病

妊娠期急性、慢性及妊娠特异性肝病的流行病学趋势

Epidemiologic Trends in Acute, Chronic, and Pregnancy-Specific Liver Diseases in Pregnancy.
PubMed 文献 · Am J Gastroenterol · 2025-07-31

这项为期10年的回顾性研究在一家三级中心纳入2014年1月1日至2023年12月31日的全部妊娠,共51,708例妊娠中1,429例(2.8%)合并至少一种肝脏疾病。妊娠期慢性肝病患病率随时间上升,主要由代谢功能障碍相关脂肪性肝病(MASLD)增加驱动,慢性病毒性肝炎减少;妊娠特异性肝病在合并慢性肝病者中更常见。

要点

  • 51,708例妊娠中1,429例(2.8%)合并至少一种肝脏疾病。
  • 妊娠期慢性肝病患病率10年间上升约2.5倍,主要由MASLD增加驱动。
  • 妊娠特异性肝病在合并慢性肝病者中更常见(如妊娠期肝内胆汁淤积症3.2% vs 0.6%)。

核心结论

  • 过去10年妊娠期慢性肝病患病率上升约2.5倍,主要由MASLD患病率上升和慢性病毒性肝炎患病率下降驱动。
  • 妊娠特异性肝病在合并慢性肝病者中显著更常见。
  • 作者认为研究结果强调肝病专科提供孕前咨询及早期产科协作对改善合并肝病孕妇结局的重要性。

研究设计与样本

  • 为期10年的回顾性研究,在一家三级中心纳入2014年1月1日至2023年12月31日的全部妊娠。
  • 肝脏疾病按急性、慢性和妊娠特异性分类,通过诊断代码识别。
  • 从电子病历收集社会人口学和妊娠相关数据,组间比较采用χ²检验和Student t检验,时间趋势采用Cochrane-Armitage检验。

主要发现

  • 共纳入51,708例妊娠,其中1,429例(2.8%)合并至少一种肝脏疾病。
  • 1,429例中85例(4.8%)为急性肝病,913例(51.8%)为慢性肝病(包括77例(4.4%)肝硬化),784例(44.5%)为妊娠特异性肝病(如妊娠期肝内胆汁淤积症、妊娠期急性脂肪肝、溶血、肝酶升高和血小板减少综合征及累及肝脏的子痫前期)。
  • 妊娠期慢性肝病患病率随时间上升,从慢性病毒性肝炎向MASLD转变(P值<0.01)。
  • 妊娠特异性肝病随时间保持稳定,但在合并慢性肝病者中更常见:妊娠期肝内胆汁淤积症3.2% vs 0.6%,子痫前期11.3% vs 6.3%,溶血、肝酶升高和血小板减少综合征0.6% vs 0.2%,妊娠期急性脂肪肝0.2% vs 0.0%,所有P<0.01。

临床怎么用

  • 作者认为研究结果强调肝病专科提供孕前咨询的重要性。
  • 作者认为早期产科协作对优化日益增多的合并肝病孕妇的结局具有重要意义。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Chronic liver diseases (CLDs) and cirrhosis are rising in reproductive-aged female patients, primarily driven by increasing alcohol-related liver disease and metabolic dysfunction-associated steatotic liver disease (MASLD). However, contemporary data on acute, chronic, and pregnancy-specific liver diseases remain limited. METHODS: This 10-year retrospective study at a tertiary center included all pregnancies from January 1, 2014, to December 31, 2023. Liver conditions-categorized as acute, chronic, and pregnancy-specific-were identified by diagnosis codes. Sociodemographic and pregnancy-related data were collected from electronic medical records. Group comparisons were performed using the χ 2 and Student t tests. Temporal trends were assessed through the Cochrane-Armitage test. RESULTS: Among 51,708 pregnancies, 1,429 (2.8%) were affected by 1 or more liver condition: 85 (4.8%) with acute, 913 (51.8%) with CLD including 77 (4.4%) with cirrhosis, and 784 (44.5%) with pregnancy-specific liver diseases (e.g., intrahepatic cholestasis of pregnancy; acute fatty liver of pregnancy; hemolysis, elevated liver enzymes, and low platelets syndrome; and preeclampsia with liver involvement). Prevalent CLD in pregnancy increased over time, with a shift from chronic viral hepatitis to MASLD ( P values <0.01). Pregnancy-specific liver conditions remained stable over time, though occurred more commonly in those with concurrent CLD (intrahepatic cholestasis of pregnancy 3.2% vs 0.6%; preeclampsia 11.3% vs 6.3%; hemolysis, elevated liver enzymes, and low platelets syndrome 0.6% vs 0.2%; and acute fatty liver of pregnancy 0.2% vs 0.0%; all P < 0.01). DISCUSSION: In this large epidemiologic study, we observed a 2.5-fold rise in CLD in pregnancy over the past 10 years, largely driven by the rising prevalence of MASLD, and declining prevalence of chronic viral hepatitis. Pregnancy-specific liver conditions were also significantly more common in those with CLD. Findings underscore the relevance of preconception counseling by hepatology providers and the importance of early obstetric collaboration to optimize outcomes for the growing number of pregnant women with preexisting liver disease.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Jutras G, Fenton C, Flemming JA, et al. Epidemiologic Trends in Acute, Chronic, and Pregnancy-Specific Liver Diseases in Pregnancy. Am J Gastroenterol. 2025. PMID: 40737002. doi:10.14309/ajg.0000000000003687

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。